The Food and Drug Administration (FDA) has issued an advisory to recall specific batches of tablets used in treating metastatic or Stage 4 breast cancer.
The FDA reported that the affected batches of Nolvadex-D 20 mg tablets [(generic name: Tamoxifen (as citrate)] contain some imperfectly sealed blister packs because of mistakes in packaging.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.